Woodline Partners LP Landos Biopharma, Inc. Transaction History

Woodline Partners LP

  • $9.97 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.7 - $15.0 $1 Million - $3.19 Million
-212,800 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$9.77 - $15.77 $5,226 - $8,436
-535 Reduced 0.25%
212,800 $3.11 Million
Q1 2021

May 17, 2021
BUY
$9.47 - $16.26 $2.02 Million - $3.47 Million
213,335 New
213,335 $2.05 Million

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email